Free Trial

KP Tissue (TSE:KPT) Shares Pass Below Two Hundred Day Moving Average of $8.45

KP Tissue logo with Consumer Defensive background

Shares of KP Tissue Inc. (TSE:KPT - Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$8.45 and traded as low as C$8.43. KP Tissue shares last traded at C$8.50, with a volume of 14,361 shares trading hands.

Analyst Ratings Changes

KPT has been the subject of several recent research reports. TD Securities upped their price objective on KP Tissue from C$8.50 to C$9.00 and gave the company a "hold" rating in a research note on Wednesday, August 14th. Desjardins dropped their price target on shares of KP Tissue from C$11.00 to C$10.00 and set a "hold" rating for the company in a research note on Wednesday, May 15th.

Check Out Our Latest Research Report on KPT

KP Tissue Price Performance

The stock has a 50 day moving average of C$8.49 and a 200 day moving average of C$8.45. The company has a market capitalization of C$84.15 million, a price-to-earnings ratio of 14.07, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37.

KP Tissue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th will be given a $0.18 dividend. The ex-dividend date is Monday, September 30th. This represents a $0.72 dividend on an annualized basis and a dividend yield of ∞. KP Tissue's dividend payout ratio (DPR) is currently 120.00%.

KP Tissue Company Profile

(Get Free Report)

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.

Read More

Should you invest $1,000 in KP Tissue right now?

Before you consider KP Tissue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.

While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines